Log In
BCIQ
Print this Print this
 

BPZE1

  Manage Alerts
Collapse Summary General Information
Company ILiAD Biotechnologies LLC
DescriptionLive-attenuated Bordetella pertussis vaccine
Molecular Target
Mechanism of Action 
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPhase I
Standard IndicationPertussis
Indication DetailsVaccinate against Bordetella pertussis and whooping cough
Regulatory Designation
PartnerInstitut National de la Sante et de la Recherche Medicale (INSERM);
Institut Pasteur

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
Get a free BioCentury trial today